O. Rosella

发表

Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.

P. Gibson, G. Young, O. Rosella, 1995, Gut.

Serum free medium increases expression of markers of differentiation in human colonic crypt cells.

P. Gibson, G. Young, O. Rosella, 1994, Gut.

Effect of topical butyrate on rectal epithelial kinetics and mucosal enzyme activities.

P. Gibson, J. Day, G. Young, 1998, Clinical science.

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

P. Gibson, J. Muir, S. Shepherd, 2009, Journal of agricultural and food chemistry.

Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals.

P. Gibson, J. Muir, S. Shepherd, 2011, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Abnormalities of the urokinase system in colonic crypt cells from patients with ulcerative colitis.

P. Gibson, O. Rosella, 1996 .

Abnormalities of the Urokinase System in Colonic Crypt Cells from Patients with Ulcerative Colitis

P. Gibson, O. Rosella, Ourania Rosella, 1996, Inflammatory bowel diseases.

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study

P. Gibson, M. Sparrow, D. V. van Langenberg, 2018, Journal of Crohn's & colitis.

Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.

P. Gibson, O. Rosella, P. Gibson, 1995, Gut.

Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro.

P. Gibson, G. Young, O. Rosella, 1994, Gastroenterology.

Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.

P. Gibson, G. Young, O. Rosella, 1994, Gut.

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.

Steven J Brown, N. Uldbjerg, B. Bibby, 2016, Gastroenterology.

Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease.

P. Gibson, J. Lubel, O. Rosella, 2017, Clinical nutrition.

Manipulating dietary intake of poorly absorbed and fermentable short-chain carbohydrates (FODMAPs): Implications for laxation and gastrointestinal health

C. K. Yao, P. Gibson, J. Muir, 2012 .

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

Steven J Brown, M. Kamm, J. Andrews, 2020, Alimentary Pharmacology and Therapeutics.

Dietary modulation of colonic mucosal urokinase activity in rats

P. Gibson, G. Young, C. Finch, 1995, Journal of gastroenterology and hepatology.

Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

R. Gearry, P. Gibson, J. Muir, 2010, Alimentary pharmacology & therapeutics.

Fructan and free fructose content of common Australian vegetables and fruit.

P. Gibson, J. Muir, S. Shepherd, 2007, Journal of agricultural and food chemistry.

Abnormal fibre usage in UC in remission

P. Gibson, J. Muir, C. Christophersen, 2014, Gut.

No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates.

Jane G Muir, Peter R Gibson, P. Gibson, 2013, Gastroenterology.

Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover

I Birchall, P. Gibson, D. Barkla, 1998, Gut.

Colonic epithelial cell activation and the paradoxical effects of butyrate.

Andrew J. Wilson, J. Mariadason, P. Gibson, 1999, Carcinogenesis.

Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch.

P. Gibson, P. De Cruz, M. Sparrow, 2021, Journal of Crohn's & colitis.

Association of Circulating Vitamin D Concentrations with Intestinal but Not Systemic Inflammation in Inflammatory Bowel Disease

P. Gibson, J. Lubel, O. Rosella, 2013, Inflammatory bowel diseases.

Neoplasia and hyperplasia of large bowel: focal lesions in an abnormal epithelium.

P. Gibson, G. Young, C. Finch, 1992, Gastroenterology.

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

J. Andrews, P. Gibson, S. Ghaly, 2018, Alimentary pharmacology & therapeutics.

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease

K. Taylor, M. Sparrow, O. Rosella, 2022, Therapeutic drug monitoring.

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

P. Gibson, S. Bell, E. Wright, 2021, Alimentary pharmacology & therapeutics.

Abnormal fibre usage in UC in remission

P. Gibson, J. Muir, C. Christophersen, 2014, Gut.

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

P. Gibson, J. Muir, S. Shepherd, 2009, Journal of agricultural and food chemistry.

Serum free medium increases expression of markers of differentiation in human colonic crypt cells.

O. Rosella, P. R. Gibson, G. Young, 1994, Gut.

Polyunsaturated fatty acids reduce non‐receptor‐mediated transcellular permeation of protein across a model of intestinal epithelium in vitro

P. Gibson, O. Rosella, Andrew H. Sinclair, 2000, Journal of gastroenterology and hepatology.

Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease.

P. Gibson, J. Lubel, O. Rosella, 2017, Clinical nutrition.

Adalimumab and infliximab levels in neonates (ERA study)

R. Gearry, G. Radford-Smith, S. Connor, 2015 .

Relationship of hydrolase activities to epithelial cell turnover in distal colonic mucosa of normal rats

J. Mariadason, G. Young, D. Barkla, 1999, Journal of gastroenterology and hepatology.

Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.

G. Young, O. Rosella, G. Rosella, 1994, Gut.